• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    7/10/23 1:50:32 PM ET
    $STRC
    $TCBP
    $TEAF
    $TGL
    Wholesale Distributors
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $STRC alert in real time by email

     

    On Monday, 65 companies hit new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE).
    • The smallest company in terms of market cap to set a new 52-week low was Biodexa Pharmaceuticals (NASDAQ:BDRX).
    • Tivic Health Systems (NASDAQ:TIVC) shares traded down 40.69% to reach its 52-week low, making it the biggest loser.
    • Chijet Motor Co (NASDAQ:CJET) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • Bristol-Myers Squibb (NYSE:BMY) shares fell to $62.30 on Monday, setting a new 52-week low with a shift of down 0.54%.
    • Humana (NYSE:HUM) shares reached a new 52-week low of $427.21 on Monday morning, moving up 0.06%.
    • Amcor (NYSE:AMCR) stock hit a new 52-week low of $9.48. The stock was down 3.77% on the session.
    • FMC (NYSE:FMC) stock hit $88.80 on Monday morning, setting a new 52-week low for a change of down 14.62%.
    • KT (NYSE:KT) shares fell to $11.10 on Monday, setting a new 52-week low with a shift of up 0.04%.
    • UGI (NYSE:UGI) shares were down 0.81% for the day, having made a 52-week low of $25.69.
    • Clearway Energy (NYSE:CWEN) shares moved down 0.29% on Monday to hit a new 52-week low of $27.38, drifting down 0.29%.
    • California Water Servs Gr (NYSE:CWT) shares set a new yearly low of $49.27 this morning. The stock was down 0.37% on the session.
    • SunPower (NASDAQ:SPWR) stock hit a new 52-week low of $8.99. The stock was up 1.49% on the session.
    • Northwest Natural Hldg (NYSE:NWN) shares reached a new 52-week low of $41.64 on Monday morning, moving up 0.12%.
    • Duckhorn Portfolio (NYSE:NAPA) stock broke to a new 52-week low of $12.54 on Monday. Shares of the company traded down 1.41%.
    • Kenon Hldgs (NYSE:KEN) stock achieved a new 52-week low on Monday morning, hitting $22.85 and moving down 2.52%.
    • Enanta Pharma (NASDAQ:ENTA) shares were up 1.69% for the day, having made a 52-week low of $19.29.
    • Chijet Motor Co (NASDAQ:CJET) stock achieved a new 52-week low on Monday morning, hitting $2.31 and moving 0.0% (flat).
    • First Foundation (NASDAQ:FFWM) shares made a new 52-week low of $3.75 on Monday. The stock was down 0.52% for the day.
    • Douglas Elliman (NYSE:DOUG) shares were up 5.6% for the day, having made a 52-week low of $2.07.
    • Tortoise Essential Assets (NYSE:TEAF) shares moved down 0.32% on Monday to hit a new 52-week low of $12.20, drifting down 0.32%.
    • Delaware Inv Natl Muni (AMEX:VFL) shares fell to $9.85 on Monday, setting a new 52-week low with a shift of down 0.2%.
    • OptiNose (NASDAQ:OPTN) stock hit $1.05 on Monday morning, setting a new 52-week low for a change of down 4.02%.
    • Cherry Hill Mortgage (NYSE:CHMI) shares fell to $4.33 on Monday, setting a new 52-week low with a shift of down 0.23%.
    • Meihua Intl Medical Techs (NASDAQ:MHUA) shares moved up 1.24% on Monday to hit a new 52-week low of $2.38, drifting up 1.24%.
    • Jerash Holdings (US) (NASDAQ:JRSH) stock dropped to a yearly low on Monday of $3.64. Shares traded down 1.35%.
    • 22nd Century Group (NASDAQ:XXII) shares hit a yearly low of $2.42. The stock was down 7.47% on the session.
    • Interactive Strength (NASDAQ:TRNR) shares fell to $2.49 on Monday, setting a new 52-week low with a shift of up 3.44%.
    • Sarcos Technology (NASDAQ:STRC) stock hit $1.46 on Monday morning, setting a new 52-week low for a change of down 6.23%.
    • Yunji (NASDAQ:YJ) stock hit a new 52-week low of $1.27. The stock was down 7.64% on the session.
    • Psychemedics (NASDAQ:PMD) shares set a new 52-week low of $4.19. The stock traded up 0.46%.
    • Tattooed Chef (NASDAQ:TTCF) shares reached a new 52-week low of $0.21 on Monday morning, moving down 11.54%.
    • Powerbridge Technologies (NASDAQ:PBTS) stock hit $0.61 on Monday morning, setting a new 52-week low for a change of down 2.25%.
    • Cineverse (NASDAQ:CNVS) stock hit a yearly low of $1.53. The stock was down 3.4% for the day.
    • Treasure Global (NASDAQ:TGL) shares fell to $0.90 on Monday, setting a new 52-week low with a shift of down 3.29%.
    • Avalon Globocare (NASDAQ:ALBT) stock set a new 52-week low of $1.19 on Monday, moving up 6.19%.
    • ABVC BioPharma (NASDAQ:ABVC) shares set a new 52-week low of $0.44. The stock traded down 2.06%.
    • FOXO Technologies (AMEX:FOXO) shares moved down 7.27% on Monday to hit a new 52-week low of $0.18, drifting down 7.27%.
    • Greenwave Tech Solns (NASDAQ:GWAV) stock dropped to a yearly low on Monday of $0.70. Shares traded down 3.1%.
    • T Stamp (NASDAQ:IDAI) shares were down 5.37% for the day, having made a 52-week low of $0.96.
    • iSun (NASDAQ:ISUN) shares set a new 52-week low of $0.37. The stock traded down 1.19%.
    • Ault Alliance (AMEX:AULT) shares fell to $4.86 on Monday, setting a new 52-week low with a shift of down 1.78%.
    • Enservco (AMEX:ENSV) stock broke to a new 52-week low of $0.29 on Monday. Shares of the company traded up 2.07%.
    • OceanPal (NASDAQ:OP) stock broke to a new 52-week low of $1.26 on Monday. Shares of the company traded down 7.56%.
    • SuperCom (NASDAQ:SPCB) shares made a new 52-week low of $0.92 on Monday. The stock was up 0.36% for the day.
    • Ra Medical Systems (AMEX:RMED) shares set a new 52-week low of $0.70. The stock traded down 5.47%.
    • Gaucho Group Holdings (NASDAQ:VINO) shares moved up 1.99% on Monday to hit a new 52-week low of $0.50, drifting up 1.99%.
    • Blue Star Foods (NASDAQ:BSFC) stock hit a new 52-week low of $1.05. The stock was down 5.65% on the session.
    • Ucommune International (NASDAQ:UK) shares made a new 52-week low of $0.50 on Monday. The stock was up 1.63% for the day.
    • G Medical Innovations (NASDAQ:GMVD) shares made a new 52-week low of $0.32 on Monday. The stock was up 1.73% for the day.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new 52-week low of $0.43. The stock traded down 1.97%.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares were down 2.76% for the day, having made a 52-week low of $3.76.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $STRC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRC
    $TCBP
    $TEAF
    $TGL

    CompanyDatePrice TargetRatingAnalyst
    Humana Inc.
    $HUM
    10/14/2025$235.00Sell
    Goldman
    FMC Corporation
    $FMC
    10/14/2025$33.00Underperform → Neutral
    BofA Securities
    Cherry Hill Mortgage Investment Corporation
    $CHMI
    10/13/2025Buy → Neutral
    Janney
    Amcor plc
    $AMCR
    10/10/2025$10.19Hold → Buy
    Stifel
    Clearway Energy Inc.
    $CWEN
    10/7/2025$34.00In-line
    Evercore ISI
    Enanta Pharmaceuticals Inc.
    $ENTA
    10/1/2025$20.00Hold → Buy
    Jefferies
    Amcor plc
    $AMCR
    9/23/2025Sector Perform
    RBC Capital Mkts
    Humana Inc.
    $HUM
    9/22/2025$295.00In-line
    Evercore ISI
    More analyst ratings

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chairman & CEO Bourla Albert

    4 - PFIZER INC (0000078003) (Issuer)

    10/17/25 5:19:03 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chairman & CEO Bourla Albert

    4 - PFIZER INC (0000078003) (Issuer)

    10/16/25 7:52:44 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Anderson David Hugo sold $472,912 worth of shares (10,509 units at $45.00), decreasing direct ownership by 17% to 51,922 units (SEC Form 4)

    4 - Northwest Natural Holding Co (0001733998) (Issuer)

    10/16/25 6:37:40 PM ET
    $NWN
    Oil/Gas Transmission
    Utilities

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & General Counsel Shao Wei-Ming bought $1,211,450 worth of Series A Perpetual Stretch Preferred Stock (12,500 units at $96.92), increasing direct ownership by 500% to 15,000 units (SEC Form 4)

    4 - Strategy Inc (0001050446) (Issuer)

    9/16/25 4:30:04 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    President & CEO Le Phong bought $11,309 worth of Series A Perpetual Stretch Preferred Stock (119 units at $95.03) (SEC Form 4)

    4 - Strategy Inc (0001050446) (Issuer)

    8/28/25 4:30:07 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    Director Sterrett Stephen E bought $85,500 worth of Ordinary Shares (10,000 units at $8.55) (SEC Form 4)

    4 - Amcor plc (0001748790) (Issuer)

    8/21/25 4:51:20 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $STRC
    $TCBP
    $TEAF
    $TGL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 11, 2024 - FDA Approves New Treatment for Hemophilia A or B

    For Immediate Release: October 11, 2024 Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies). “Today’s approval of Hympavzi pro

    10/11/24 2:12:15 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Humana with a new price target

    Goldman initiated coverage of Humana with a rating of Sell and set a new price target of $235.00

    10/14/25 8:50:11 AM ET
    $HUM
    Medical Specialities
    Health Care

    FMC Corp upgraded by BofA Securities with a new price target

    BofA Securities upgraded FMC Corp from Underperform to Neutral and set a new price target of $33.00

    10/14/25 8:37:36 AM ET
    $FMC
    Major Chemicals
    Industrials

    Cherry Hill Mortgage downgraded by Janney

    Janney downgraded Cherry Hill Mortgage from Buy to Neutral

    10/13/25 8:47:59 AM ET
    $CHMI
    Real Estate Investment Trusts
    Real Estate

    $STRC
    $TCBP
    $TEAF
    $TGL
    SEC Filings

    View All

    SEC Form S-3 filed by Tivic Health Systems Inc.

    S-3 - Tivic Health Systems, Inc. (0001787740) (Filer)

    10/17/25 5:01:09 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 6-K filed by Ucommune International Ltd

    6-K - Ucommune International Ltd (0001821424) (Filer)

    10/17/25 6:05:57 AM ET
    $UK
    Real Estate

    T Stamp Inc. filed SEC Form 8-K: Other Events

    8-K - T Stamp Inc (0001718939) (Filer)

    10/16/25 6:34:15 PM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    $STRC
    $TCBP
    $TEAF
    $TGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer

    First and only combination regimen to improve survival when used before and after surgical cystectomy in cisplatin-ineligible patients with muscle-invasive bladder cancerUnprecedented survival results from pivotal Phase 3 EV-303 trial show potential for PADCEV plus KEYTRUDA to redefine standard of careTOKYO and NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE:PFE) today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as KEYNOTE-905) for PADCEV™ (enfortumab vedotin), a Nectin-4 directed antibody-drug conjugate, in combination with KEYTRUDA™ (pembrolizumab), a PD-1

    10/18/25 10:30:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025

    REDMOND, Wash. and PRINCETON, N.J., Oct. 17, 2025 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE:BMY) today announced the oral presentation of the first disclosure of the safety and efficacy data from the global phase I US-Lung-101 study (NCT05983432) of iza-bren (BL-B01D1), a potentially first-in-class EGFR x HER3 bispecific antibody-drug conjugate (ADC), at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. Iza-bren is jointly developed by SystImmune and Bristol Myers Squibb under a collaboration and exclusive license agreement in territories outside of Mainland China. In August 2025, iza-

    10/17/25 10:00:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain

    In largest head-to-head randomized clinical trial evaluating the two medicines, Dovato (DTG/3TC) met the primary endpoint, demonstrating sustained non-inferior efficacy versus Biktarvy (BIC/FTC/TAF) in virologically suppressed adults who switched from their prior regimen In latest data, Dovato led to significantly less weight gain and fewer drug-related adverse events compared to BIC/FTC/TAF through two years of follow-up ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 96-week findings from PASO DOBLE (GeSIDA 11720 study) showing that Dovato (dolutegravir/lamivudine [DTG/3TC]) is as effective as Bikta

    10/17/25 7:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Leadership Updates

    Live Leadership Updates

    View All

    First Foundation Bank Appoints Dean R. Glassberg as Chief Credit Officer

    First Foundation Inc. (NYSE:FFWM), a financial services company with two wholly-owned operating subsidiaries, First Foundation Advisors ("FFA") and First Foundation Bank ("FFB"), is pleased to announce the appointment of Dean R. Glassberg as Executive Vice President, Chief Credit Officer of FFB, effective October 14, 2025. In this role, Mr. Glassberg will lead FFB's credit strategy, risk governance, underwriting standards, portfolio monitoring, and credit operations, partnering closely with senior leadership to support disciplined growth. "We are thrilled to welcome Dean to First Foundation," said Thomas C. Shafer, CEO of First Foundation Inc. "His proven track record of transformation in

    10/14/25 6:55:00 AM ET
    $FFWM
    Major Banks
    Finance

    Amcor Appoints Stephen R. Scherger as Executive Vice President and Chief Financial Officer

    Michael Casamento to return home to Australia to be closer to his family on a full-time basis; Will leave the Company as a result, remaining in an advisory role until June 30, 2026 to support transition Company reaffirms Fiscal 2026 and first quarter Fiscal 2026 outlook ZURICH, Oct. 9, 2025 /PRNewswire/ -- Amcor (NYSE:AMCR, ASX: AMC)), a global leader in consumer packaging and dispensing solutions for Nutrition, Health, Beauty and Wellness, announced the appointment of Stephen R. Scherger as Executive Vice President and Chief Financial Officer, effective Nov. 10, 2025. Mr. Scherger succeeds Michael Casamento, who after ten years as Amcor's Chief Financial Officer has decided to return home t

    10/9/25 4:30:00 PM ET
    $AMCR
    $GPK
    $MIDD
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Containers/Packaging
    Industrial Machinery/Components

    Cineverse Technology Group Launches Matchpoint™ 3.0 with New Features, Brand Identity

    LOS ANGELES, Oct. 6, 2025 /PRNewswire/ -- Cineverse Corp (NASDAQ:CNVS), a next-generation entertainment studio, has today launched Matchpoint™ 3.0, the newest version of the Company's proprietary, state-of-the-art, automated media supply chain platform that is radically changing the way video content is managed and delivered.  This comes with the launch of a new brand identity, seen now at www.matchpoint.tv, updating and modernizing the UI's look-and-feel, making it easier-to-use for customers.  Trusted by top studios and streaming platforms, Matchpoint is leading the evolutio

    10/6/25 1:15:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $STRC
    $TCBP
    $TEAF
    $TGL
    Financials

    Live finance-specific insights

    View All

    Clearway Energy, Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025

    PRINCETON, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE:CWEN, CWEN.A)) plans to report Third Quarter 2025 financial results on Tuesday, November 4, 2025. Management will present the results during a conference call and webcast at 5:00 p.m. Eastern. A live webcast of the conference call, including presentation materials, can be accessed through the Company's website at http://www.clearwayenergy.com and clicking on "Presentations & Webcasts" under the Investor Relations section. The webcast will be archived on the site for those unable to listen in real time. About Clearway Energy Clearway Energy, Inc. is one of the largest owners of clean energy generation assets

    10/14/25 6:30:00 AM ET
    $CWEN
    Electric Utilities: Central
    Utilities

    Strategy Announces ATM and BTC Activity Updates

    Raised $27.3 million; Purchased 220 BTC; Now Holds 640,250 BTC Strategy Inc (NASDAQ:STRF) ("Strategy"), the largest corporate holder of bitcoin and the world's first Bitcoin Treasury Company, today announced the following updates with respect to its at-the-market ("ATM") offering programs and bitcoin holdings: ATM Update ATM Program Summary     During Period October 6, 2025 to October 12, 2025     As of October 12, 2025     Shares Sold     Notional Value (in millions) (1)     Net Proceeds (in millions) (2)     Available for Issuance and Sale (in millions) STRF ATM

    10/13/25 8:00:00 AM ET
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    Humana Inc. to Release Third Quarter 2025 Results on November 5, 2025

    Humana Inc. (NYSE:HUM) will release its financial results for the third quarter 2025 (3Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 5, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025. A webcast of the 3Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIbac7b49877b94c62a538fdf08464989

    10/10/25 4:15:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care